Early Discontinuation of P2Y12 Antagonists and Adverse Clinical Events Post–Percutaneous Coronary Intervention: A Hospital and Primary Care Linked Cohort

Background Early discontinuation of P2Y12 antagonists post–percutaneous coronary intervention may increase risk of stent thrombosis or nonstent recurrent myocardial infarction. Our aims were to (1) analyze the early discontinuation rate of P2Y12 antagonists post–percutaneous coronary intervention, (...

Descripció completa

Dades bibliogràfiques

Autors principals:	Daniel E. Harris, Arron Lacey, Ashley Akbari, Daniel R. Obaid, Dave A. Smith, Geraint H. Jenkins, James P. Barry, Mike B. Gravenor, Julian P. Halcox
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2019-11-01
Col·lecció:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Matèries:	adherence clopidogrel discharge therapy discontinuation percutaneous coronary intervention
Accés en línia:	https://www.ahajournals.org/doi/10.1161/JAHA.119.012812
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!